Valuation: Gennex Laboratories Limited

Market Cap 1.73B 18.16M 15.89M 14.65M 13.53M 25.68M 26.11M 175M 68.76M 853M 68.19M 66.71M 2.93B P/E 2024
26x
P/E 2025 15.4x
Enterprise Value 1.46B 15.28M 13.37M 12.33M 11.39M 21.61M 21.97M 147M 57.85M 718M 57.38M 56.13M 2.47B EV / Sales 2024
3.67x
EV / Sales 2025 1.79x
Free-Float
65.03%
Yield 2024 *
-
Yield 2025 -
05-30 Gennex Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-14 Gennex Laboratories Limited Resignation of Shilpa Bung, Non-Executive Independent Women Director, Effective February 14, 2026 CI
02-14 Gennex Laboratories Limited Appoints Khushbu Kachhawa as Additional Director (Non-Executive Independent Women Director) CI
02-14 Gennex Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
11-14 Gennex Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
14/08/25 Gennex Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/05/25 Gennex Laboratories Limited Announces Resignation of Dr. Sch Dharma Rao as Non-Executive Non-Independent Director, Effective May 30, 2025 CI
30/05/25 Gennex Laboratories Limited Appoints Sandeep Kumar Daga as Non-Executive Non-Independent Director CI
30/05/25 Gennex Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2025 CI
14/02/25 Gennex Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
14/02/25 Gennex Laboratories Limited Announces Resignation of Mohammed Khaleequr Rahman as Non-Executive Non-Independent Director CI
14/11/24 Gennex Laboratories Limited Approves the Appointment of Akkali Santosh Kumar as Chief Financial Officer CI
01/10/24 Gennex Laboratories Limited Announces Board Changes CI
1 day+2.27%
1 week-2.26%
Current month-7.37%
1 month-1.10%
3 months-3.31%
6 months-26.77%
Current year-30.56%
1 week 8.65
Extreme 8.65
10.48
1 month 8.65
Extreme 8.65
12.5
Current year 7.05
Extreme 7.05
14.77
1 year 7.05
Extreme 7.05
17.25
3 years 6.15
Extreme 6.15
29
5 years 4.81
Extreme 4.81
29
10 years 1.32
Extreme 1.32
29
Manager TitleAgeSince
Chief Executive Officer 40 17/05/2012
Director of Finance/CFO - 11/11/2024
Compliance Officer 62 19/04/2023
Director TitleAgeSince
Director/Board Member - 29/05/2025
Chairman 40 -
Director/Board Member - 20/12/2020
Change 5-day change 1-year change 3-year change Capi.($)
+2.27%-2.26%-31.94%+41.86% 25.29M
-2.33%-2.09%+49.88%+170.51% 1,060B
-0.82%-2.30%+63.79%+62.00% 619B
-0.73%-4.98%+28.91%+82.99% 438B
+0.33%-1.17%+31.07%+27.09% 333B
-0.02%-2.85%+29.15%+45.24% 282B
-3.89%-11.22%+22.81%+27.30% 267B
+0.66%-1.42%-26.59%-37.71% 218B
-0.06%-2.88%+23.07%+62.33% 196B
-3.72%-1.10%+18.41%+70.56% 161B
Average -0.83%-3.15%+20.86%+55.22% 357.39B
Weighted average by Cap. -1.31%-2.96%+36.75%+83.91%

Financials

2024 2025
Net sales 867M 9.09M 7.95M 7.34M 6.78M 12.86M 13.07M 87.65M 34.42M 427M 34.14M 33.4M 1.47B 1.38B 14.46M 12.65M 11.67M 10.77M 20.44M 20.79M 139M 54.74M 679M 54.29M 53.11M 2.34B
Net income 132M 1.38M 1.21M 1.11M 1.03M 1.95M 1.99M 13.32M 5.23M 64.9M 5.19M 5.07M 223M 181M 1.9M 1.66M 1.53M 1.42M 2.69M 2.73M 18.32M 7.19M 89.28M 7.13M 6.98M 307M
Net Debt -413M -4.33M -3.79M -3.49M -3.23M -6.12M -6.22M -41.74M -16.39M -203M -16.26M -15.9M -699M -275M -2.88M -2.52M -2.32M -2.15M -4.07M -4.14M -27.77M -10.91M -135M -10.82M -10.58M -465M
Logo Gennex Laboratories Limited
Gennex Laboratories Limited is an India-based active pharmaceutical ingredient manufacturing company. The Company is engaged in the business of manufacturing of bulk drugs and intermediaries. It offers products in various therapeutic categories, including expectorant (mucolyte), relaxant (skeletal muscle relaxant), antihistamines, urinary tract analgesic, antifungals called triazoles, tricyclic antidepressant, acting muscle relaxants, muscle relaxant, selective serotonin reuptake inhibitors (SSRIS), and xanthine oxidase inhibitors. Its products include Guaifenesin, Methocarbamol, Fexofenadine Hcl, Phenazopyridine Hcl, Fluconazole, Melitracen Hcl, Mephenesin, Chlorphenesin, Sertraline Hcl and Allopurinol. The Company has manufacturing facilities in India which cater to both domestic and international markets. Its international markets include Bangladesh, Bolivia, China, Colombia, Costa Rica, Cuba, Germany, Indonesia, Iran, Iraq, Israel, Jordan, Kenya, South Korea, Malaysia and Mexico.
Employees
115
Date Price Change Volume
10/07/26 ₹9.930 +2.27% 400,152
09/07/26 ₹9.710 +7.06% 520,187
08/07/26 ₹9.070 -9.57% 1,024,635
07/07/26 ₹10.03 -2.05% 470,870
06/07/26 ₹10.24 +0.79% 215,120
  1. Stock Market
  2. Stocks
  3. GENNEX6 Stock